Colistin: old antibiotic, new tricks

Written by Annie Coulson (Editor)

Colistin antibiotic murepavadin

Scientists from Imperial College London (UK) and the University of Texas at Austin (TX, USA) have revealed how ‘last-resort’ antibiotic colistin kills bacteria and have discovered a potential way to enhance the antibiotic’s efficacy. A team led by Andrew Edwards (Imperial College London), in collaboration with colleagues from the University of Texas has uncovered colistin’s bacteria killing mechanism and a potential way to enhance that antibacterial activity, which could revolutionize how the antibiotic is used. Colistin is an ‘antibiotic of last-resort’ that is used to treat superbugs such as Escherichia coli, Acinetobacter baumannii and Pseudomonas aeruginosa, all of which can...

To view this content, please register now for access

Join our member community for FREE to access a collection of journal and online-only features, including:

  • Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
  • The latest news and journal updates delivered straight to your inbox when you want it
  • Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
  • Priority registration to webinars, panel discussions and events
  • Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!